Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Change in Account Payables (2022 - 2025)

Envoy Medical's Change in Account Payables history spans 4 years, with the latest figure at $1.0 million for Q3 2025.

  • For Q3 2025, Change in Account Payables rose 498.81% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $751000.0, up 123.14%, while the annual FY2024 figure was -$19000.0, 103.45% down from the prior year.
  • Change in Account Payables for Q3 2025 was $1.0 million at Envoy Medical, up from -$43000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.6 million in Q3 2023 and bottomed at -$3.4 million in Q4 2023.
  • The 4-year median for Change in Account Payables is $168000.0 (2024), against an average of $123133.3.
  • The largest YoY upside for Change in Account Payables was 2435.05% in 2023 against a maximum downside of 691.6% in 2023.
  • A 4-year view of Change in Account Payables shows it stood at $583000.0 in 2022, then plummeted by 691.6% to -$3.4 million in 2023, then surged by 93.56% to -$222000.0 in 2024, then surged by 553.15% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Change in Account Payables are $1.0 million (Q3 2025), -$43000.0 (Q2 2025), and $10000.0 (Q1 2025).